InvestorsHub Logo
Followers 18
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: flipper44 post# 177789

Wednesday, 06/13/2018 4:27:27 PM

Wednesday, June 13, 2018 4:27:27 PM

Post# of 704591
Stupp’s data was controlled and, some may argue, optimized. You could have a placebo with Optune, but I also understand his argument that it would inconvenience patients for no reason (Just like the device currently inconveniences patients) I think Optune adds a benefit over SOC, but there were some arguable shortcuts to the pure science of the trial.

There could be some arguments about the screening of the P3 DCVAX trial (most notably the number of patients screened), but from what I have seen, it doesn’t seem that the patients were cherry picked.

I still think Stupp is motivated to compete with the DCVax technology. While he may be a respected neurosurgeon, he also is a human. Nobody really likes losing. The real question about his character is whether he can lose with integrity or if he cheats to win.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News